Sourced from:Manufacturer Authorized Distributor
Quick Summary
Adlumab 40mg Injection
Last updated on 26 Sep 2026 | 11:06 AM (IST)
₹5818
MRP: ₹28351.64
(You Save ₹22533.64)
1 PREFILLED SYRINGE(s) OF 0.8ML
Adlumab 40mg Injection is a prescription medicine used to treat various autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, and Crohn’s disease. It contains adalimumab, a biologic agent that works by blocking tumour necrosis factor-alpha (TNF-α), a protein involved in inflammation, thereby reducing symptoms and preventing joint or tissue damage. Adlumab 40mg Injection should be used under strict medical supervision as part of a comprehensive treatment plan.
Sourced from:Manufacturer Authorized Distributor
Adlumab 40mg Injection
Salt Composition
ADALIMUMABMarketer
RPG LIFE SCIENCES LTD
Prepaid Only. Non-Returnable.
79% OFF
₹5818
MRP: ₹28,351.64
Inclusive of all taxes
79% Off
Salt Composition
ADALIMUMABMarketer
RPG LIFE SCIENCES LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Azimbra 40mg Injection
ABBOTT
₹ 5512.00/injection
5% cheaper
Exemptia 40mg Injection
ZYDUS CADILA
₹ 5682.00/injection
2% cheaper
Mabura 40mg Injection PFS
HETERO HEALTHCA...
₹ 5918.00/injection
2% costlier
Plamumab 40mg Injection
CIPLA LTD
₹ 6393.00/injection
10% costlier
Introduction
Adlumab 40mg Injection contains the active ingredient Adalimumab. It is an antirheumatic agent that belongs to the class of medications called TNF (tumour necrosis factor) inhibitors. It is used alone or with other medications to relieve the symptoms of certain autoimmune disorders. It is used to treat rheumatoid arthritis (a condition in which the body attacks its joints, causing pain, swelling, and loss of function), polyarticular juvenile idiopathic arthritis (a condition that affects children in which the body attacks its own joints, causing pain, swelling, loss of function, and delays in growth and development).
It is also indicated to treat enthesitis-related arthritis, ankylosing spondylitis (a condition in which the body attacks the joints of the spine and other areas, causing pain and joint damage), axial spondyloarthritis without radiographic evidence of ankylosing spondylitis, psoriatic arthritis (a condition that causes joint pain and swelling and scales on the skin), plaque psoriasis, hidradenitis suppurativa (a skin disease that causes pimple-like bumps in the armpits, groin, and anal area), Crohn’s disease, ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum), and non-infectious uveitis (swelling and inflammation of different areas of the eye). Adlumab 40mg injection substitute includes Adalimumab injection, based on the same strength and prescribed indication.
Do not use Adlumab Injection if you are allergic to adalimumab or any of the other ingredients present in this medicine. Do not take this medicine if you have active tuberculosis or other severe infections. Do not consume this medicine if you have moderate or severe heart failure. Inform your physician if you have any active infections before starting the treatment. Tell your doctor if you have lung problems, heart diseases, liver or kidney disorders before initiating the treatment. If you are pregnant, think you may be pregnant, or are planning to have a baby, ask your doctor for advice about taking this medicine. Adlumab 40mg injection price varies by retailer and location. You can buy Adlumab 40mg online.
Uses
Adlumab 40mg uses are to treat:
Polyarticular juvenile idiopathic arthritis
Enthesitis-related arthritis
Ankylosing spondylitis
Axial spondyloarthritis without radiographic evidence of ankylosing spondylitis
Psoriatic arthritis
Plaque psoriasis
Hidradenitis suppurativa
Crohn’s disease
Ulcerative colitis
Non-infectious uveitis
How Adlumab 40mg Injection Works
The active ingredient in this medicine is a human monoclonal antibody. Monoclonal antibodies are proteins that attach to a specific target. The target of Adlumab 40mg Injection is a protein called tumor necrosis factor (TNFα), which is involved in the immune (defense) system and at increased levels in the inflammatory diseases. By attaching to TNFα, Humira decreases inflammation in these diseases.
Interaction of Adlumab 40mg Injection with other drugs
Anakinra (Injection Route) Severe
Avoid combined use. Using both medicines together can markedly increase the risk of serious and potentially life threatening infections.Abatacept (Injection Route) Severe
Concurrent use is not recommended. The combination leads to excessive immune suppression without added therapeutic benefit and raises infection risk.Tocilizumab (Injection Route) Severe
Do not use together unless clearly advised by a specialist. Combined therapy may significantly weaken immune defenses and increase severe infection risk.Natalizumab (Injection Route) Severe
Avoid combination. Using both drugs together can greatly increase susceptibility to infections due to profound immune suppression.Vedolizumab (Injection Route) Severe
Combination should be avoided. There is an increased risk of serious infections and blood related abnormalities when used together.Live Vaccines such as MMR or Varicella (Injection Route) Severe
Live vaccines should not be given during adalimumab therapy. The suppressed immune response may lead to vaccine related infections.
Storage Conditions
Store in a refrigerator (2°C – 8°C).
Do not freeze.
Protect the medicine from light and excessive moisture.
Keep the medicine out of reach of children and pets
How to consume Adlumab 40mg Injection
Your doctor will decide the Adlumab 40mg dosage, duration, and frequency of administration based on your disease condition, severity and other factors. Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
This medicine is to be administered by injection under the skin (subcutaneously). Your doctor or other healthcare professional will train you on how to use this injection. Do not self-administer this injection until you get trained. Your doctor will decide the dose, duration, and frequency of administration based on your disease condition, severeity and other factors.
Safety Advice for Adlumab 40mg Injection
Breast Feeding
Adlumab 40mg Injection can be used during breastfeeding. However, inform your physician if you are breastfeeding.
Alcohol
It is unknown whether consuming alcohol is safe during the treatment with Adlumab 40mg Injection. Consult your doctor for more advice.
Liver
Adlumab 40mg Injection should be taken cautiously in patients with liver problems. Inform your physician if you have any liver diseases before initiating the treatment.
Lungs
Adlumab 40mg Injection should be taken cautiously in patients with lung problems. Inform your physician if you have any lung diseases before initiating the treatment.
Driving
Adlumab 40mg Injection may have a small effect on your ability to drive, cycle or use machines. Room spinning sensation and vision disturbances may occur after taking this medicine
Pregnancy
Do not take Adlumab 40mg Injection during pregnancy unless your doctor says. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for at least 5 months after the last dose.
Side Effects
Adlumab injection side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Inj adalimumab 40 mg side effects are:
Common
Injection site reactions
Rash
Headache
Sinusitis
Upper respiratory infections
Fever
Serious
Heart problems
Abnormal heart beat
Severe skin reactions
GI bleeding
Abnormal blood count values
Liver injury
Bone problems
Infections
Severe respiratory problems
Expert Tips
Vaccines and Infections: Avoid certain vaccines during treatment and inform your doctor about current or past hepatitis B infection.
Injection Technique: Learn proper self injection methods, rotate injection sites each time, and avoid injecting into irritated or damaged skin.
Missed Dose: Take the missed dose as soon as remembered unless it is close to the next dose, and never double the dose.
FAQs about Adlumab 40mg Injection
Q1.
How long does it take for Adlumab 40mg Injection to start working?
The response to Adlumab 40mg Injection can vary among individuals and the condition being treated. Some individuals may experience improvement in symptoms within a few weeks, while others may take longer. It is important to follow the healthcare provider's instructions and allow sufficient time for the medication to take effect.
Q2.
Can Adlumab 40mg Injection increase the risk of infections?
Adlumab 40mg Injection may increase the risk of serious bacterial, viral, or fungal infections. It is essential to promptly report any signs of infection to a healthcare provider while taking this medicine. Inform your physician if you have or had any active infections.
Q3.
What are the common side effects of Adlumab 40mg Injection?
Common side effects of Adlumab 40mg Injection may include injection site reactions, such as pain, redness, or swelling. Other possible side effects include headaches, upper respiratory infections, nausea, and rash. Serious side effects are rare but can occur.
Q4.
How long can I take Adlumab 40mg Injection?
The duration of Adlumab 40mg Injection treatment can vary depending on the individual's condition and response to the medication. In some cases, this medicine may be used as a long-term maintenance therapy, while treatment duration may be shorter in other situations. It is important to follow the healthcare provider's guidance regarding the appropriate duration of treatment.
Q5.
Can Adlumab 40mg Injection be used in individuals with kidney or liver impairment?
Adlumab 40mg Injection may require dosage adjustments or caution in individuals with kidney or liver impairment. Healthcare providers will assess the patient's situation and determine the appropriate dosage based on renal and hepatic function.
Fact Box
Molecule name: | Adalimumab |
Therapeutic class: | Antirheumatic agent, Monoclonal antibody |
Pharmacological class: | TNF inhibitors |
Indications: | 1. Rheumatoid arthritis 2. Polyarticular juvenile idiopathic arthritis 3. Enthesitis-related arthritis 4. Ankylosing spondylitis 5. Axial spondyloarthritis without radiographic evidence of ankylosing spondylitis 6. Psoriatic arthritis 7. Plaque psoriasis 8. Hidradenitis suppurativa 9. Crohn’s disease 10. Ulcerative colitis 11. Non-infectious uveitis |
References
Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Immunosuppressants, Tolerogens, and Immunostimulants, 12th edition, 2011, 1018.
KD Tripathi, Essentials of Medical Pharmacology, Antirheumatoid and antigout drugs, 7th edition, 2013, 213.
AbbVie Ltd, Electronic medicines compendium (emc), [ Revised on April 2021] [ Accessed on July 2023], https://www.medicines.org.uk/emc/files/pil.2150.pdf
AbbVie Inc, US Food and Drug Administration, [ Revised on Feb 2021] [ Accessed on July 2023], https://www.rxabbvie.com/pdf/humira.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Karpagam A.
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 26 Sep 2026 | 11:06 AM (IST)
Want to know more?
Read Our Editorial Policy